Healthcare innovation raises a question that is too often avoided: how to fund it concretely, without betraying the purpose of the project? Between venture capital that dilutes and public markets that impose delays, few models allow the community to be directly involved.
Galeon made a different choice. After nine years of development at the heart of hospitals, deployed across 19 institutions with more than 10,000 healthcare professionals and 3 million patient records, the project is entering an acceleration phase. To fund it, Galeon is opening a public bond programme, accessible to all, until 12 April 2026.
A public bond is a clear, contractual and community-driven financing mechanism — the opposite of the opacity that too often characterises fundraising in healthcare.
In this article, we explain what these bonds are in concrete terms, why Galeon chose this model, and what it means for subscribers.
A bond is, above all, a relationship of trust formalised by a contract. You lend a sum of money to a company for a defined period. In return, it commits to paying you interest each year and repaying the principal at maturity.
This model is fundamentally different from equity investment. By subscribing to a bond, you become a creditor — not a shareholder. You are not exposed to daily valuation fluctuations, you do not participate in strategic decisions, and you know the exact repayment terms from the outset.
This clarity is precisely what makes bonds powerful: you know what you're lending, to whom, for how long, and under what conditions.
The term "public" does not refer to a state issuer. It means that the programme is open to a broad audience, within a regulated framework. Historically, this mechanism has connected citizens' savings to tangible projects — infrastructure, industries, essential services. It is experiencing a revival today, driven by a growing need for meaning and transparency in investment decisions.
Galeon's challenge is no longer to prove that its technology works. With 19 hospitals, more than 10,000 active healthcare professionals and millions of recorded consultations, the proof has been established in the field.
The focus is now on acceleration: deploying across more institutions, strengthening technical and medical teams, replicating the infrastructure internationally, and continuing to develop secure medical artificial intelligence.
Public bonds address this objective in a coherent way. They make it possible to raise funds without diluting capital or giving up strategic stakes in the project. They also allow those who believe in this vision — patients, healthcare professionals, committed investors — to be directly involved.
Financing Galeon through bonds is an extension of the same logic as the project itself: transparency, stakeholder alignment, and respect for everyone's sovereignty.
The amounts collected will be allocated to four priority areas:
This loan does not fund a prototype. It funds the scaling of an already operational system, tested under real conditions, by healthcare professionals in practice.
In France, interest received via bonds qualifies as income from movable capital. It is subject to the flat-rate withholding tax (PFU), commonly known as the "flat tax", currently set at 30% — including income tax and social levies.
Under the Galeon programme, taxes are withheld at source. Subscribers must nonetheless declare their investments in their annual tax return. The option for the progressive income tax scale remains available if it proves more favourable, depending on each individual's tax situation.
As each tax situation is personal, this article provides a general framework for understanding. A financial or tax advisor remains best placed to refine the calculation based on your profile.
Galeon public bonds allow any investor to lend directly to a digital health company already operational in 19 hospitals. Unlike shares, this mechanism offers a clear contractual framework: fixed interest, defined duration, capital repayment at maturity. In France, the income generated is subject to the 30% flat tax, withheld at source. This programme is not subject to an AMF prospectus : the DIS document available on the Atlantis platform constitutes the regulatory reference. The subscription deadline is 12 April 2026. For Galeon, this financing choice is not purely a financial decision: it is an act of consistency with its philosophy of transparency, data sovereignty and community alignment.




